Bioptik Technology Incorporation

TPEX:4161 Stock Report

Market Cap: NT$1.7b

Bioptik Technology Incorporation Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure17.5yrs

Recent management updates

Recent updates

Do Investors Have Good Reason To Be Wary Of Bioptik Technology Incorporation's (GTSM:4161) 1.2% Dividend Yield?

Apr 12
Do Investors Have Good Reason To Be Wary Of Bioptik Technology Incorporation's (GTSM:4161) 1.2% Dividend Yield?

Bioptik Technology Incorporation (GTSM:4161) Is Making Moderate Use Of Debt

Feb 16
Bioptik Technology Incorporation (GTSM:4161) Is Making Moderate Use Of Debt

Is Bioptik Technology Incorporation (GTSM:4161) A Strong Dividend Stock?

Dec 25
Is Bioptik Technology Incorporation (GTSM:4161) A Strong Dividend Stock?

CEO

Bioptik Technology Incorporation has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Jin-Chang Yang
GM & Chairman of the Board24.3yrsno data6.16%
NT$ 103.4m
Yì Cheng Chen
Director22.5yrsno data1.39%
NT$ 23.3m
Yue Qin Ye
Director19.5yrsno data3.43%
NT$ 57.6m
Li Si Cai
Director19.5yrsno data3%
NT$ 50.3m
Qing Zhang Wen
Director14.1yrsno data0.39%
NT$ 6.6m
Nai-Ming Liu
Independent Director13.2yrsno datano data
Dun Ren Zheng
Director15.5yrsno data0.12%
NT$ 1.9m
Wen Xiang Cai
Director19.5yrsno data1.74%
NT$ 29.1m
Senrong Wang
Director10.5yrsno data0.71%
NT$ 11.9m
Yigong Cai
Independent Director4.5yrsno datano data

17.5yrs

Average Tenure

Experienced Board: 4161's board of directors are seasoned and experienced ( 17.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 05:21
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bioptik Technology Incorporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
PeiChing LeeYuanta Research